HEALTH

Scientists get closer to blood test for Alzheimer’s disease

Jul 28, 2020, 12:40 PM
Utah Covid-19 cases numbers...
Photo: Getty Images

By MARILYNN MARCHIONE AP Chief Medical Writer

New study results are boosting hopes that there soon may be a simple, reliable way to help family doctors diagnose the most common form of dementia. Researchers say an experimental blood test was able to distinguish people with Alzheimer’s disease from those without it in several studies. The accuracy ranged from 89% to 98%, though the test still needs more validation. Several companies are developing these tests, which measure a protein that damages the brains of people with the disease. The results were discussed at an Alzheimer’s conference Tuesday and some were published in the Journal of the American Medical Association.

An experimental blood test was highly accurate at distinguishing people with Alzheimer’s disease from those without it in several studies, boosting hopes that there soon may be a simple way to help diagnose this most common form of dementia.
Developing such a test has been a long-sought goal, and scientists warn that the new approach still needs more validation and is not yet ready for wide use.

But Tuesday’s results suggest they’re on the right track. The testing identified people with Alzheimer’s vs. no dementia or other types of it with accuracy ranging from 89% to 98%.

“That’s pretty good. We’ve never seen that” much precision in previous efforts, said Maria Carrillo, the Alzheimer’s Association’s chief science officer.

Dr. Eliezer Masliah, neuroscience chief at the U.S. National Institute on Aging, agreed.

“The data looks very encouraging,” he said. The new testing “appears to be even more sensitive and more reliable” than earlier methods, but it needs to be tried in larger, more diverse populations, he said.

The institute had no role in these studies but financed earlier, basic research toward blood test development.

Results were discussed at the Alzheimer’s Association International Conference taking place online because of the coronavirus pandemic. Some results also were published in the Journal of the American Medical Association.

More than 5 million people in the United States and many more worldwide have Alzheimer’s. Current drugs only temporarily ease symptoms and do not slow mental decline.

The disease is usually diagnosed through tests of memory and thinking skills, but that’s very imprecise and usually involves a referral to a neurologist. More reliable methods such as spinal fluid tests and brain scans are invasive or expensive, so a simple blood test that could be done in a family doctor’s office would be a big advance.

Last year, scientists reported encouraging results from experimental blood tests that measure abnormal versions of amyloid, one of two proteins that build up and damage Alzheimer’s patients’ brains. The new work focuses on the other protein — tau — and finds that one form of it called p-tau217 is a more reliable indicator. Several companies and universities have developed experimental p-tau217 tests.

Dr. Oskar Hansson of Lund University in Sweden led a study of Eli Lilly’s test on more than 1,400 people already enrolled in dementia studies in Sweden, Arizona, and Colombia. They included people with no impairment, mild impairment, Alzheimer’s and other neurological diseases.

The p-tau217 test outperformed a host of other measures for indicating which patients had Alzheimer’s as verified by brain scans. It also was comparable to the brain scans and some spinal tests in accuracy.

The Arizona portion of the study included 81 people who had donated their brains upon death, so researchers were able to show that blood testing while they were alive closely matched evidence of disease later.

The Colombia part of the study included people with a rare gene that virtually destines them to develop Alzheimer’s at a young age, typically in their 40s. In those with the gene, p-tau217 blood levels started to rise “around 20 years before symptoms,” Hansson said.

The study’s sponsors include the U.S. National Institutes of Health, Swedish government health groups, the Alzheimer’s Association, many foundations and several companies. Some study leaders work for Lilly or consult for the company.

Two other research groups independently reported evidence for p-tau217 testing at the conference.

Scientists at the University of California, San Francisco, found it helped distinguish people with Alzheimer’s from those with another neurological disease — frontotemporal lobar degeneration — with 96% accuracy in a study of 617 people.

Dr. Suzanne Schindler of Washington University in St. Louis, Missouri, also found p-tau217 better than some other indicators for revealing which patients had plaques in the brain — the hallmark of Alzheimer’s.

“When patients come to me with changes in their memory and thinking, one of the major questions is, what’s the cause? Is it Alzheimer’s disease or is it something else?” she said. If tau testing bears out, “it would help us diagnose people earlier and more accurately.”
Schindler has already launched a larger study in a diverse population in St. Louis. Researchers have done the same in Sweden.
If benefits are confirmed, Masliah, Carrillo, and others say they hope a commercial test would be ready for wide use in about two years.
___
Marilynn Marchione can be followed on Twitter at http://twitter.com/MMarchioneAP
The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute’s Department of Science Education. The AP is solely responsible for all content.

Health

Dogs and cats cannot get the avian flu...
Aimee Cobabe

Avian flu in Utah causes worry in pet owners

A Utah veterinarian explained there is no reason to worry about your cats or dogs getting the avian flu. He encouraged pet vaccinations.
2 months ago
FILE: A Boeing 737-932ER operated by Delta Airlines takes off from JFK Airport on August 24, 2019 i...
Pete Muntean, CNN

Three US airlines extend olive branch to passengers banned for mask violations

The move comes after two dizzying days of rulings and countermoves on the federal mask mandate for public transportation.
2 months ago
Mask mandate...
MICHAEL BALSAMO and ZEKE MILLER Associated Press

Justice Dept. to appeal order voiding travel mask mandate

WASHINGTON (AP) — The Justice Department is filing an appeal seeking to overturn a judge’s order that voided the federal mask mandate on planes and trains and in travel hubs, officials said Wednesday. The notice came minutes after the Centers for Disease Control and Prevention asked the Justice Department to appeal the decision handed down […]
2 months ago
Utah national parks no longer have a mask mandate...
Chandler Holt

Masks no longer required in national parks

Since a federal judge struck down the CDC's transportation mask mandate, guests in national parks can choose if they'd like to wear a mask or not.
2 months ago
New eligibility rules for pandemic-EBT program...
Waverly Golden

New eligibility guidelines for Pandemic-EBT

Utah households will have to apply for free or reduced-price meal benefits with their local school by May 6 to possibly receive Pandemic-EBT.
2 months ago
Intermountain Healthcare facilities upgrade landscaping...
Waverly Golden

Intermountain Healthcare landscaping gets a new look

Landscaping at Intermountain Healthcare facilities is getting a new look to help save water as Utah still experiences a bad drought.
2 months ago

Sponsored Articles

Prescription opioid...
Know Your Script

Prescription opioid misuse | How to protect your family from the opioid epidemic

Studies have shown that prescription opioid misuse has increased since COVID-19. So what do you need to know about these opioids?
...

Tax Tuesday: The Most Common Mistakes People Make When Filing Their Taxes

Fortunately, for most average earners, they will not end up owing overpayments received for the Child Tax Credit in 2021.
...

Tax Tuesday: How will last year’s child tax credits affect you?

Fortunately, for most average earners, they will not end up owing overpayments received for the Child Tax Credit in 2021.
...

Tax Tuesday: Key Information Before the Filing Deadline

Businesses can receive a credit of up to $5,000 per employee in 2020 and up to $21,000 per employee in 2021.
national heart month...
Intermountain Healthcare

National Heart Month: 5 Lifestyle Changes to Make Today to Keep You Heart Healthy

Heart disease is the leading cause of death for both men and women. One person dies every 36 seconds in the United States from cardiovascular disease
Joseph Smith Memorial Building...
Temple Square

The Joseph Smith Memorial Building is an icon of Salt Lake City | Why hosting an event at this beautiful location will make you a hero this year

Here's why hosting an event at the iconic Joseph Smith Memorial Building in downtown Salt Lake City will make you a hero this year.
Scientists get closer to blood test for Alzheimer’s disease